Slide 1: ont Y
ont Y
Slide 2: Disclaimer
DISCLAIMER This presentation also contains estimates and other statistical data made by independent parties and by the Company relating to market size the concentration of our voting power as a result of our dual class structure; our status as a foreign private issuer; and other risk factors set and
Slide 3: Our vision is to transform the global beauty & wellness market
OUR VISION IS TO TRANSFORM THE GLOBAL BEAUTY & WELLNESS MARKET THROUGH ISRAELI TECHNOLOGY & ENTREPRENEURIAL THINKING FOR THE BENEFIT OF CONSUMERS ALL OVER THE WORLD. 3
Slide 4: Our technology platform supports a portfolio of powerhouse brands
OUR TECHNOLOGY PLATFORM SUPPORTS A PORTFOLIO OF POWERHOUSE BRANDS 4
Slide 5: $ODD Financial Highlights
$ODD FINANCIAL HIGHLIGHTS $596M $148M $268M Net revenue, Adjusted EBITDA1, Cash, cash equivalents, LTM Q224 LTM Q224 & investments4 +31% 25% $114M YoY net revenue Adjusted EBITDA2 Free cash flow3, growth, LTM Q224 margin, LTM Q224 LTM Q224 Note: 1. Adjusted EBITDA is a supplemental measure of our pe
Slide 6: A rare combination of scale + growth + profitability
A RARE COMBINATION OF SCALE + GROWTH + PROFITABILITY +57% +28% +46% +69% +101% NET REVENUE GROWTH1 $509M $325M $223M $404M NET REVENUE $317M $107M $110M $39M $70M ADJUSTED EBITDA2 $27M FY21 FY22 FY23 H123 H124 Note: 1. Percentages reflect year-over-year growth rates for the same period of the prior
Slide 7: Q2 2024 results exceeded guidance
Q2 2024 RESULTS EXCEEDED GUIDANCE Q2 2024 REVISED JUNE INITIAL MAY ACTUAL GUIDANCE GUIDANCE NET REVENUE GROWTH 27% ~25% 22 to 25% GROSS MARGIN 72.2% 71.0% 71.0% ADJUSTED EBITDA1 $62mn $60mn $53mn to $56mn ADJUSTED DILUTED EPS2 $0.82 $0.69 $0.61 to 0.64 Note: 1. Adjusted EBITDA is a supplemental meas
Slide 8: Raised FY 2024 and introduced Q3 2024 financial outlook
RAISED FY 2024 AND INTRODUCED Q3 2024 FINANCIAL OUTLOOK GUIDANCE PRIOR Q3 2024 FY 2024 FY 2024 FY 2024 Current Current May March NET REVENUE $115 to 117mn $633 to 640mn $626 to 635mn $620 to 630mn GROSS MARGIN 68.0% 71.0% 71.0% 70.5% ADJUSTED EBITDA1 $21 to 23mn $142 to 146mn $139 to 143mn $136 to 1
Slide 9: Q2 2024 Highlights
Q2 2024 HIGHLIGHTS In millions Q2 2024 vs Q2 2023 Net Revenue $192.8 +27% Gross Margin 72.2% +154 bps Adjusted EBITDA $62.3 +49% 1 Adjusted EBITDA margin 32.3% +470 bps 2 Adjusted Diluted EPS $0.82 +46% 3 Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by,
Slide 10: FY 2023 Highlights
FY 2023 HIGHLIGHTS In millions FY 2023 vs FY 2022 Net Revenue $508.7 +57% Gross Margin 70.4% +320 bps Adjusted EBITDA $107.3 +172% 1 Adjusted EBITDA margin 21.1% +900 bps 2 Adjusted Diluted EPS $1.31 nm 3 Free-cash flow $85.4 +133% 4 Note: 1. Adjusted EBITDA is a supplemental measure of our performa
Slide 11: Appendix
APPENDIX 11
Slide 12: Reconciliations to adjusted metrics
RECONCILIATIONS TO ADJUSTED METRICS U.S. dollar in thousands (except per share data) Three Months Ended Twelve Months Ended June 30, December 31, 2024 2023 2023 2022 (Unaudited) Net Income 45,491 45,492 $ 29,997 $ 58,534 $ 21,728 Financial income, net (3,670) (894) (4,283) (1,247) Taxes on Income 11
Slide 13: Reconciliation of net cash provided by operating activities to free cash flow
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW U.S. dollar in thousands (except per share data) Year Ended December 31, 2023 2022 (Unaudited) Net operating cash flow $ 87,455 $ 39,032 Purchase of property and equipment (2,101) (2,347) Free cash flow1 $ 85,354 $ 36,685